Summary
- Current Price
- As of today, AGMB price is $11.48, down -0.17% in the most recent trading session on
- Current Price All-Time High
- AGMB price is currently -34.21% below its historical high of $17.45 set on
- Market Cap
- AGMB current market cap is $565M, with unknown 1-year change
- PE Ratio
- AGMB PE ratio is unknown
- Revenue
- AGMB current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AGMB is on
Profile
| Metric | Value |
|---|---|
| Full Name | AgomAb Therapeutics NV |
| Ticker | NASDAQ: AGMB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Belgium |
| IPO | |
| Indexes | Not included |
| Website | agomab.com |
| Employees | 57 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $11.48 | |
| Price, 1D Change | -0.17% | |
| $565M | ||
| - | ||
| - | ||
| 1.67 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.45 | ||
| EPS, 1Y Change | -41.05% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.45 | ||
| EPS Estimate | N/A | -$1.83 |
| EPS Est. Change | N/A | -26.52% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $11.48 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$82.33 | -$1.45 | +98.24% | |
| -$1.83 | N/A | -26.52% | |
| -$2.00 | N/A | -37.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $11.48 | |
| $12.62 | ||
| SMA 200 vs Price | +9.93% | |
| $11.41 | ||
| SMA 50 vs Price | -0.65% | |
| 1.67 | ||
| $0.90 | ||
| 52.20 | ||
| 55.52% | ||
| 76.71% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.45 | ||
| -$247.20K | ||
| - | ||
| -$69.60M | ||
| - | ||
| -$70.59M | ||
| - | ||
| -$69.35M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 6.49 | ||
| 6.49 | ||
| - | ||
| - | ||
| 10.54 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 3.68 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $153.74M | ||
| $136.84M | ||
| $180.52M | ||
| $141.64M | ||
| $26.78M | ||
| $21.83M | ||
| $1.47M | ||
| $292.40K | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $70.59M | ||
| $69.35M | ||
| $247.20K | ||
| $0.00 | ||
| $247.20K | ||
| $0.00 | ||
| -$577.80K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$58.39M | ||
| -$37.25M | ||
| -$381.50K | ||
| $4,500.00 | ||
| -$58.40M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | ||
| Leerink Partners | ||
| JP Morgan |
Analyst sentiment
Institutional ownership
Screeners with AGMB
FAQ
What is the ticker symbol for AgomAb Therapeutics NV?
The ticker symbol for AgomAb Therapeutics NV is NASDAQ:AGMB
Does AgomAb Therapeutics NV pay dividends?
No, AgomAb Therapeutics NV does not pay dividends
What sector is AgomAb Therapeutics NV in?
AgomAb Therapeutics NV is in the Healthcare sector
What industry is AgomAb Therapeutics NV in?
AgomAb Therapeutics NV is in the Biotechnology industry
What country is AgomAb Therapeutics NV based in?
AgomAb Therapeutics NV is headquartered in Belgium
When did AgomAb Therapeutics NV go public?
AgomAb Therapeutics NV initial public offering (IPO) was on May 29, 2024
Is AgomAb Therapeutics NV in the S&P 500?
No, AgomAb Therapeutics NV is not included in the S&P 500 index
Is AgomAb Therapeutics NV in the NASDAQ 100?
No, AgomAb Therapeutics NV is not included in the NASDAQ 100 index
Is AgomAb Therapeutics NV in the Dow Jones?
No, AgomAb Therapeutics NV is not included in the Dow Jones index
When was AgomAb Therapeutics NV last earnings report?
AgomAb Therapeutics NV's most recent earnings report was on April 23, 2026
When does AgomAb Therapeutics NV report earnings?
The next expected earnings date for AgomAb Therapeutics NV is May 29, 2026
Data Sources & References
- AGMB Official Website agomab.com
- AGMB Profile on Yahoo Finance finance.yahoo.com/quote/AGMB
- AGMB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agmb